Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Olga Kantor, M.D.

Concepts (130)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms542025211564.050 Why?
Neoadjuvant Therapy20202228963.380 Why?
Mastectomy16202418522.620 Why?
Sentinel Lymph Node Biopsy1420257432.170 Why?
Axilla1520246291.740 Why?
Carcinoma, Intraductal, Noninfiltrating520249341.520 Why?
Neoplasm Staging162024112491.510 Why?
Receptors, Estrogen13202522431.110 Why?
Pancreaticoduodenectomy520175161.110 Why?
Carcinoma, Ductal, Breast7202010921.030 Why?
Lymph Node Excision10202312761.010 Why?
Chemotherapy, Adjuvant13202435501.000 Why?
Mastectomy, Segmental820249610.870 Why?
Neoplasm Recurrence, Local13202494250.840 Why?
Receptor, erbB-29202525860.830 Why?
Receptors, Progesterone6202511450.810 Why?
Pancreatic Neoplasms6201754420.710 Why?
Carcinoma, Lobular420194800.680 Why?
Antineoplastic Combined Chemotherapy Protocols92024118430.630 Why?
Biological Factors120201580.630 Why?
Lymphatic Metastasis7202329300.620 Why?
Mesenteric Veins12017870.570 Why?
Carcinoma, Pancreatic Ductal2201717550.530 Why?
Pancreatic Fistula120171490.520 Why?
Pancreatectomy220178240.510 Why?
Lymph Nodes9202334720.500 Why?
Testicular Neoplasms120218060.500 Why?
Pancreatic Diseases120173530.480 Why?
Female5520253969430.440 Why?
Adenocarcinoma5201664000.420 Why?
Radiation Oncology120195730.410 Why?
Patient Selection3201942660.410 Why?
Prognosis152025300280.410 Why?
Combined Modality Therapy4201985590.400 Why?
Societies, Medical2202439550.370 Why?
Postmenopause4202425190.370 Why?
Humans6520257684510.360 Why?
Survival Rate112025128750.360 Why?
Practice Guidelines as Topic2201974510.360 Why?
Tamoxifen220249680.320 Why?
Vascular Surgical Procedures1201715090.310 Why?
Quality Indicators, Health Care1201818130.300 Why?
Breast3202319760.300 Why?
Guideline Adherence1201822390.300 Why?
Radiotherapy, Adjuvant3201817940.290 Why?
Antineoplastic Agents, Hormonal1201515360.280 Why?
Middle Aged2820252234180.280 Why?
Retrospective Studies172023818340.260 Why?
Health Knowledge, Attitudes, Practice1201940490.230 Why?
Quality of Health Care1201843400.210 Why?
Biology220242910.210 Why?
Aged1820241715200.210 Why?
Databases, Factual5201880810.210 Why?
Quality Improvement1201738580.190 Why?
Models, Biological1201895050.190 Why?
Follow-Up Studies92024394300.190 Why?
Physicians1201946150.190 Why?
ROC Curve2201936240.180 Why?
Neoplasm Invasiveness2201936370.160 Why?
United States102020731210.160 Why?
Hormones120228700.150 Why?
Proportional Hazards Models32017125610.150 Why?
Healthcare Disparities2202434120.140 Why?
Treatment Outcome52024654090.120 Why?
Postoperative Complications12017158800.120 Why?
Length of Stay3201765210.120 Why?
Postoperative Hemorrhage120174200.110 Why?
Area Under Curve1201816400.110 Why?
Blood Loss, Surgical120176430.110 Why?
Kaplan-Meier Estimate1202465370.110 Why?
Social Class1202120000.100 Why?
Anastomosis, Surgical120169930.100 Why?
Shock, Septic120177740.090 Why?
Blood Transfusion1201713080.090 Why?
Early Detection of Cancer2202232300.090 Why?
Health Status Disparities1202218760.090 Why?
Disease-Free Survival1202168560.090 Why?
Clinical Trials as Topic2202480510.090 Why?
Risk Factors62024749150.090 Why?
Patient Preference120179480.090 Why?
Adult820242235420.080 Why?
Poverty1202127190.080 Why?
Neoplasms, Second Primary1201510620.070 Why?
Socioeconomic Factors1202178630.070 Why?
Regression Analysis1201763530.070 Why?
Reoperation1201743420.070 Why?
Male920213647810.070 Why?
Gene Expression Profiling2202095070.070 Why?
Risk Assessment22017243110.060 Why?
Aged, 80 and over52020596800.060 Why?
Carcinoma1201723410.060 Why?
Laparoscopy1201720560.060 Why?
Cohort Studies22020417970.060 Why?
Stomach Neoplasms1201614840.060 Why?
Mammography3202224360.060 Why?
Electronic Health Records1202248770.060 Why?
Age Factors22018184780.060 Why?
Decision Making1201739610.060 Why?
Survival Analysis12016101250.050 Why?
Patient Readmission1201733080.050 Why?
Coronavirus Infections1202031160.050 Why?
Pneumonia, Viral1202032400.050 Why?
Prospective Studies22024549140.050 Why?
Magnetic Resonance Imaging22020368400.050 Why?
Randomized Controlled Trials as Topic12017103580.040 Why?
Time Factors22020402710.040 Why?
Risk Reduction Behavior1202411200.040 Why?
Cross-Sectional Studies12019263510.040 Why?
Benchmarking1202210580.030 Why?
Neoplasm, Residual1202010140.030 Why?
Ultrasonography, Mammary120172410.030 Why?
Antineoplastic Agents12016137080.030 Why?
Data Collection1202233290.030 Why?
Neoplasms12021223860.020 Why?
Survivors1202223810.020 Why?
Medical Oncology1202423470.020 Why?
Remission Induction1201724080.020 Why?
Gastrectomy120166960.020 Why?
Pandemics2202187530.020 Why?
SEER Program1201514760.020 Why?
Propensity Score1201619710.020 Why?
Perioperative Care1201610460.020 Why?
Risk1202096420.020 Why?
Health Personnel1202133840.020 Why?
Registries1202283730.020 Why?
Comorbidity12020106010.020 Why?
Prevalence12022158800.020 Why?
Reproducibility of Results12017202310.010 Why?
Young Adult12020600450.010 Why?
Adolescent12020891680.010 Why?
Kantor's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (130)
Explore
_
Co-Authors (37)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2025 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.